Screener
Corcept Therapeutics CORT Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Corcept Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: Corcept Therapeutics’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050613
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Proceeds from purchases under the Employee Stock Purchase Program | 6,200 | 4,990 |
| Repurchases of common stock in connection with Stock Repurchase Program | — | (130,451) |
| Cash paid to satisfy statutory withholding requirement for net settlement of cashless option exercises and vesting of restricted stock grants | (17,218) | (28,251) |
| Net cash used in financing activities | (1,277) | (142,737) |
| Net effect of exchange rate changes on cash, cash equivalents and restricted cash | (250) | 1,794 |
| Net decrease in cash, cash equivalents and restricted cash | (9,456) | (24,920) |
| Cash, cash equivalents and restricted cash, at beginning of period | 121,745 | 128,665 |
| Cash, cash equivalents and restricted cash, at end of period | $112,289 | $103,745 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Corcept Therapeutics's financing cash flow?
- Corcept Therapeutics (CORT) reported financing cash flow of -$2.04M in Q2 2026.
- How has Corcept Therapeutics's financing cash flow changed year-over-year?
- Corcept Therapeutics's financing cash flow increased by 98.0% year-over-year, from -$102.93M to -$2.04M.
- What is the long-term trend for Corcept Therapeutics's financing cash flow?
- Over 4 years (2021 to 2025), Corcept Therapeutics's financing cash flow has grown at a -7.6% compound annual growth rate (CAGR), from -$302.59M to -$220.37M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about Corcept Therapeutics's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude